Maen Abdelrahim Download Headshot

Maen Abdelrahim, MD, PhD, B Pharm

  • Houston Methodist gastrointestinal medical oncologist
  • Assistant Professor of Medicine in Oncology, Houston Methodist Institute for Academic Medicine
  • Director, Houston Methodist Cockrell Center for Advanced Therapeutics
  • Assistant Professor of Medicine, Weill Cornell Medical College
Media Contact: Amy Rose , 412.613.1428

Maen Abdelrahim, MD, PhD, B Pharm

Request Interview
Media Contact: Amy Rose , 412.613.1428

Areas of Expertise

  • Cancer clinical trials
  • Cholangiocarcinoma
  • Clinical research
  • Colon cancer
  • Esophageal cancer
  • Gastric cancer
  • Gastrointestinal stromal tumors (GIST)
  • Liver cancer
  • Neuroendocrine cancers
  • Pancreatic cancer
  • Rectal cancer
  • Small intestine cancer
  • Translation research

Credentials

BACHELOR OF PHARMACY
Isra University - Amman, Jordan
DOCTOR OF PHILOSOPHY
Pharmacology and Toxicology | Texas A&M University - College Station, Texas
MEDICAL SCHOOL
Texas A&M University College of Medicine - Houston, Texas
RESIDENCY
Internal Medicine | Baylor College of Medicine - Houston, Texas
FELLOWSHIP
Medical Oncology | Duke University School of Medicine - Durham, N.C.

Publications

Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail
Abdelrahim, M, Esmail, A, Kasi, A, Esnaola, NF, Xiu, J, Baca, Y & Weinberg, BA 2024, , npj Precision Oncology, vol. 8, no. 1, 85. https://doi.org/10.1038/s41698-024-00571-4

Molecular profiling in the management of hepatocellular carcinoma
Soliman, N, Saharia, A, Abdelrahim, M & Connor, AA 2024, , Current opinion in organ transplantation, vol. 29, no. 1, pp. 10-22. https://doi.org/10.1097/MOT.0000000000001124

Immunotherapy and transplantation for hepatocellular carcinoma
Tabrizian, P, Abdelrahim, M & Schwartz, M 2024, , Journal of Hepatology, vol. 80, no. 5, pp. 822-825. https://doi.org/10.1016/j.jhep.2024.01.011

Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy
Xue, G, Li, X, Kalim, M, Fang, J, Jiang, Z, Zheng, N, Wang, Z, Li, X, Abdelrahim, M, He, Z, Nikiforov, M, Jin, G & Lu, Y 2024, , Cancer Cell. https://doi.org/10.1016/j.ccell.2024.03.001

Transplant Oncology: An Emerging Discipline of Cancer Treatment
Abdelrahim, M, Esmail, A, Abudayyeh, A, Murakami, N, Victor, D, Kodali, S, Cheah, YL, Simon, CJ, Noureddin, M, Connor, A, Saharia, A, Moore, LW, Heyne, K, Kaseb, AO, Gaber, AO & Ghobrial, RM 2023, , Cancers, vol. 15, no. 22, 5337, pp. 5337. https://doi.org/10.3390/cancers15225337

Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response
Parvathareddy, V, Selamet, U, Sen, AA, Mamlouk, O, Song, J, Page, VD, Abdelrahim, M, Diab, A, Abdel-Wahab, N & Abudayyeh, A 2023, , Cancers, vol. 15, no. 21, 5181. https://doi.org/10.3390/cancers15215181

What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society
Bhat, M, Dondossola, D, Varghese, R, Czigany, Z, Emamaullee, J, Ghinolfi, D, Al-Adra, D, Bonaccorsi-Riani, E, Pang, L, Boteon, YL, Brüggenwirth, I, Pavan-Guimaraes, J, Ho, CM, Yuksel, M, Zarrinpar, A, Abdelrahim, M, Barbas, AS, Mas, V, Selzner, M & Martins, PN 2023, , Transplantation, vol. 107, no. 4, pp. 808-814. https://doi.org/10.1097/TP.0000000000004476

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
Abboud, K, Umoru, G, Esmail, A, Abudayyeh, A, Murakami, N, Al-Shamsi, HO, Javle, M, Saharia, A, Connor, AA, Kodali, S, Ghobrial, RM & Abdelrahim, M 2023, , Cancers, vol. 15, no. 5, 1433. https://doi.org/10.3390/cancers15051433

Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion
Mohankumar, K, Wright, G, Kumaravel, S, Shrestha, R, Zhang, L, Abdelrahim, M, Chapkin, RS & Safe, S 2023, , Cancer Immunology, Immunotherapy, vol. 72, no. 12, pp. 3985-3999. https://doi.org/10.1007/s00262-023-03530-3

451 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving Atezolizumab
Xu, J, Burns, EA, Gee, K, Wiechmann, C, Zhang, Y, Kieser, RB, Umoru, G, Shah, S, Sun, K, Abdelrahim, M & Esmail, A 2023, , Journal for immunotherapy of cancer, vol. 11, no. Suppl 1, pp. A502-A502. https://doi.org/10.1136/jitc-2023-SITC2023.0451

1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
Wiechmann, C, Gee, K, Burns, EA, Xu, J, Zhang, Y, Crenshaw, A, Esmail, A, Kieser, RB, Umoru, G, Muhsen, I, Sun, K, Gong, Z, Shah, S, Singh, M, Zhang, J, Efstathiou, E & Abdelrahim, M 2023, , Journal for immunotherapy of cancer, vol. 11, no. Suppl 1, pp. A1360-A1360. https://doi.org/10.1136/jitc-2023-SITC2023.1233

1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)
Gee, K, Wiechmann, C, Burns, EA, Xu, J, Zhang, Y, Esmail, A, Crenshaw, A, Kieser, RB, Umoru, G, Muhsen, I, Sun, K, Gong, Z, Shah, S, Singh, M, Zhang, J, Bernicker, E & Abdelrahim, M 2023, , Journal for immunotherapy of cancer, vol. 11, no. Suppl 1, pp. A1361-A1361. https://doi.org/10.1136/jitc-2023-SITC2023.1234

960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)
Abdelrahim, M, Esmail, A, He, AR, Franses, J, Bhan, I, Victor, III, DW, Kodali, S, Connor, AA, Saharia, A, Brdiges, C, Tin, T, Brewer, C, Jurdi, A, Liu, MC & Ghobrial, RM 2023, , Annals of Oncology, vol. 34, pp. S600. https://doi.org/10.1016/j.annonc.2023.09.2106


Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
Esmail, A, Badheeb, M & Abdelrahim, M 2023, . in EH Gad (ed.), Pancreatic Cancer: Updates in Pathogenesis, Diagnosis and Therapies. IntechOpen, Rijeka. https://doi.org/10.5772/intechopen.110887


Circulating tumor DNA (ctDNA) and disease recurrence in early stage pancreatic cancer. Journal of Clinical Oncology
Gong, Z, Esmail, A & Abdelrahim, M 2023, , Journal of Clinical Oncology, vol. 41, no. 16_suppl, pp. e16313-e16313. https://doi.org/10.1200/JCO.2023.41.16_suppl.e16313

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology: Cancers
Abboud, K, Umoru, G, Esmail, A, Abudayyeh, A, Murakami, N, Al-Shamsi, HO, Javle, M, Saharia, A, Connor, AA, Kodali, S, Ghobrial, RM & Abdelrahim, M 2023, .. https://doi.org/10.3390/cancers15051433



Languages

  • English
  • Spanish